PPARβ down-regulation is involved in high glucose-induced endothelial injury via acceleration of nitrative stress

Chuang Yang1, Lai Xue2, Yang Wu3

  • 1Department of Pharmacology, Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing Key Laboratory of Drug Metabolism, College of Pharmacy, Chongqing Medical University, Chongqing 400016, PR China.

Microvascular Research
|October 26, 2021
PubMed

Insights

High glucose impairs blood vessel function by reducing Peroxisome proliferator-activated receptor beta (PPARβ) and nitric oxide (NO) production. Activating PPARβ with GW0742 protects against this damage, suggesting a therapeutic target for diabetic vascular disease.

Area of Science:

  • Vascular Biology
  • Endocrinology
  • Diabetology

Background:

  • Endothelial injury is central to diabetic vascular complications.
  • Peroxisome proliferator-activated receptor beta (PPARβ) is implicated in diabetes mellitus (DM) and its complications.
  • The precise molecular mechanisms of PPARβ in DM-induced endothelial dysfunction require further elucidation.

Purpose of the Study:

  • To investigate the role of PPARβ in high glucose-induced endothelial dysfunction.
  • To explore the relationship between PPARβ, nitric oxide (NO) production, and nitrative stress in diabetic conditions.
  • To evaluate the therapeutic potential of PPARβ activation in mitigating endothelial damage.

Main Methods:

  • Rat aortic rings were incubated under high glucose conditions.
  • Expression levels of PPARβ, endothelial nitric oxide synthase (eNOS), and inducible nitric oxide synthase (iNOS) were measured at mRNA and protein levels.
  • Nitric oxide (NO) and 3-nitrotyrosine concentrations were assessed.
  • The effects of GW0742 (PPARβ agonist), GSK0660 (PPARβ antagonist), and N-G-nitro-L-arginine methyl ester (NOS inhibitor) were evaluated.

Main Results:

  • High glucose impaired endothelium-dependent relaxation and endothelial structure.
  • High glucose significantly decreased PPARβ and eNOS expression while increasing iNOS and 3-nitrotyrosine.
  • Reduced NO concentration was observed under high glucose conditions.
  • GW0742 treatment reversed high glucose-induced endothelial dysfunction.
  • GSK0660 and NOS inhibition counteracted the protective effects of GW0742.

Conclusions:

  • High glucose-induced endothelial dysfunction in rat aorta involves the down-regulation of PPARβ, potentially mediated by nitrative stress.
  • PPARβ activation demonstrates protective effects against high glucose-induced endothelial damage.
  • Targeting the PPARβ-nitrative stress pathway may offer a novel therapeutic strategy for diabetic vascular complications.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
14.2K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.1K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.3K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.1K